Continuous Integration And Continuous DeliveryDevopsSoftware ArchitectureTypescriptAmazon Web ServicesMicroservicesOperationsSkill DevelopmentTechnical Specs
Expert (9+ years)
New York City Metropolitan
Clinical Trial Financial Management Software for Biopharma
40+ employees
B2BHealthcareSaaSFinance
Open for applications
Role
Who you are
Bachelor's or Master’s degree in Computer Science, Information Technology, or related field
10+ years' experience in software development and architecture
Proficiency in programming languages (Typescript preferred)
Strong understanding of software design patterns and principles
Experience with microservices architecture and cloud platforms (AWS, Azure, GCP)
Strong knowledge of databases (SQL and NoSQL)
Familiarity with DevOps practices and CI/CD Pipelines (Terraform preferred)
Strong leadership presence and communication skills
Ability to work independently and with remote/hybrid teams
Desirables
Bias towards experimentation
Decision-making confidence
Experience in FP&A, Clinical Data, or Clinical Trials
Sense of humor
What the job involves
Develop and maintain scalable, performant, and secure software architecture.
Provide technical guidance and mentorship to development teams, promoting coding standards.
Collaborate closely with the Product Team and other stakeholders to translate requirements into technical solutions.
Assess and recommend tools, frameworks, and technologies to improve software development processes.
Create and maintain design patterns, workflows, and specifications documentation.
Conduct code reviews to ensure quality and adherence to architectural standards.
Address technical challenges with innovative solutions and stay updated with emerging technologies.
Auxilius is a data-driven platform that empowers Biotechs to take control of clinical trial financial management, optimizing spend and managing risk to enhance the pursuit of trial outcomes. The organization leverages its expertise in data systems and technology to enable the drug development process, ensuring more efficient pathways to bringing life-saving drugs to market.